Dicerna Pharmaceuticals Inc (NASDAQ:DRNA)

38.17
Delayed Data
As of Dec 06
 -0.075 / -0.20%
Today’s Change
19.06
Today|||52-Week Range
40.14
+73.29%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues184.0K295.0K2.3M6.2M
 
 
 
 
 
Depreciation And Amortization727.0K840.0K778.0K774.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses62.5M59.2M62.1M66.6M
 
 
 
 
 
Research And Development44.0M41.7M37.0M45.7M
 
 
 
 
 
Total Operating Expenses63.2M60.0M62.9M67.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-63.0M-59.7M-60.6M-61.2M
 
 
 
 
 
Extraordinary Charge0.000.000.00-29.7M
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-62.8M-59.5M-60.0M-88.9M
 
 
 
 
 
Preferred Dividend0.000.00-20.1M0.00
 
 
Net Income-62.8M-59.5M-60.0M-88.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS20.3M20.7M21.9M55.6M
 
 
 
 
 
Shares To Calculate EPS Diluted20.3M20.7M21.9M55.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$3.09-$2.87-$3.66-$1.60
 
 
 
 
 
EPS Diluted-$3.09-$2.87-$3.66-$1.60